News
August 19, 2011 - Neovasc Inc. accomplished $4.7 million in financing to complete the COSIRA clinical trial for the Neovasc Reducer to treat refractory angina. The company will also advance the Tiara project to develop a transcatheter device to treat the mitral valve regurgitation.
August 19, 2011
News
August 19, 2011 - Endologix Inc. said a ruling this week will likely aid its defense in a stent graft patent litigation case filed by Cook Medical.
August 19, 2011
News
August 19, 2011 — NeoStem Inc., an international biopharmaceutical company, reported progress toward commencement of a Phase II clinical trial for AMR-001 for the treatment of acute myocardial infarction. The stem cell product is from Amorcyte Inc., a NeoStem subsidiary.
August 19, 2011Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Feature
August 18, 2011 — The antiplatelet agent prasugrel (trade name Effient), in combination with aspirin, was associated with 26 percent relative risk reduction in cardiovascular death, myocardial infarction or stroke. The results were from a sub-analysis of patients from the TRITON-TIMI 38 study. This was compared to treatment with clopidogrel (trade name Plavix - 8.3 percent vs. 11 percent, respectively, p<0.0001). This corresponds to a 2.7 percent absolute risk reduction for patients treated with prasugrel.
August 19, 2011
Technology
August 18, 2011 – At the 39th Annual AHRA Meeting and Exposition, Fujifilm Medical Systems U.S.A. announced the commercial availability of Synapse Mobility, a zero-footprint application that enables access to Fujifilm's suite of Synapse products from hand-held mobile devices, as well as Macintosh- or Windows-based PCs. Using the Web browser of their choice, radiologists and referring physicians can now have on-the-go access to the images and information stored in Synapse PACS and Synapse RIS, increasing accessibility to patient information and improving workflow.
August 18, 2011
News
August 18, 2011 - A new KLAS report, "Positron Emission Tomography (PET)/Computed Tomography (CT) 2011-New Technologies in Focus," measures the innovative pairing of nuclear medicine scan technologies and reviews of the top three vendors in the market space: GE Healthcare, Philips and Siemens.
August 18, 2011Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
August 17, 2011 – THA Group, a free standing in-home health company serving coastal Georgia and South Carolina, announced that it will be partnering with Cardiocom to expand its chronic telehealth program providing advanced home telehealth technology to patients with chronic conditions. Cardiocom is a developer, manufacturer and clinical service provider of telehealth solutions.
August 18, 2011
News
August 17, 2011 – Veterinarians at the Phoenix Zoo welcomed the help of the associate chief of cardiovascular surgery at St. Joseph's Heart and Lung Institute of Phoenix, Brian deGuzman, M.D., to perform a delicate surgery on the oldest mandrill in the United States.
August 18, 2011
Technology
August 17, 2011 – At the 2011 American Hospital Radiology Administrators conference (AHRA), Fujifilm Medical Systems U.S.A. announced its entry into the portable ultrasound market with the commercial availability of the Fazone CB. Designed to meet the needs of the point-of-care and mobile healthcare environments, the Fazone CB is a compact and lightweight unit that produces high-quality images quickly and easily for on-the-go clinicians.
August 18, 2011Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News
August 17, 2011 — The Society of Cardiovascular Computed Tomography (SCCT) announced the election of James K. Min, M.D., FSCCT, as its new president and John R. Lesser, M.D., FSCCT, as president-elect of the organization. Jeffrey J. Carr, M.D., FSCCT, is the vice president and Ricardo C. Cury, M.D. is joining the executive committee as treasurer. The announcement was made official at the sixth annual scientific meeting, recently held in Denver, Colo.
August 17, 2011
News
August 17, 2011 — A scientist at the Gladstone Institutes has discovered how a gene known as SIRT3 contributes to a suite of health problems, offering new insight into how to combat these potentially fatal conditions.
August 17, 2011
News
August 17, 2011 — OrbusNeich announced its Genous stent showed no significant difference in target vessel failure (TVF) rate at two years from the Taxus Liberte paclitaxel-eluting stent in patients with de novo coronary artery lesions at high risk for restenosis. The two-year follow-up data from the prospective, randomized TRIAS pilot study were published in Catheterization and Cardiovascular Interventions.
August 17, 2011Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News
August 17, 2011 — Our Lady of Lourdes Medical Center performed its first “hybrid” heart surgery and what is believed to be the first such procedure in southern New Jersey. Arthur T. Martella, M.D., chief of cardiothoracic surgery at Lourdes, and Anil G. Kothari, M.D., FACC, FSCA & I of Lourdes Health System affiliate South Jersey Heart Group, performed the procedure.
August 17, 2011
Technology
August 17, 2011 – Enhanced communication, accessibility to remote physicians and improved workflow are some of the benefits that hospitals and radiology departments can expect to gain from MD2GO, a new remote HD IP camera system from Sony Medical. Making its debut to the field of radiology during the Annual Meeting of the Association for Medical Imaging Management (AHRA), Dallas, Texas, Aug. 14 – 17, MD2GO leverages Sony’s leading visual imaging technologies to bring advanced communication to radiology.
August 17, 2011
News
August 17, 2011 – Abbott announced today that the first patient in Japan has been treated with the Absorb bioresorbable vascular scaffold (BVS) as part of the ABSORB EXTEND clinical trial. Abbott's BVS restores blood flow by opening a clogged vessel and providing support to the vessel until the device dissolves within approximately two years, leaving patients with a treated vessel free of a permanent metallic implant. The device received CE Mark approval in the European Union (EU) for the treatment of coronary artery disease and is under clinical investigation in several countries around the world. The first patient in Japan was treated in the ABSORB EXTEND clinical trial by Shigeru Saito, M.D., director, Cardiology and Catheterization Laboratories, and vice president, Shonan Kamakura Hospital, Kanagawa, Japan.
August 17, 2011© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now